Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mainz Biomed NV MYNZ

Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.


NDAQ:MYNZ - Post by User

Post by BullPath77on Nov 20, 2024 10:16am
20 Views
Post# 36321589

What’s the Exit Plan for $MYNZ Bulls?

What’s the Exit Plan for $MYNZ Bulls?
For those long on $MYNZ, what’s your game plan? Holding for FDA approval? Swing trading off the volatility? Personally, I’m eyeing $0.50-$0.60 as my first sell zone if we see a reversal. Not married to the stock—just looking to ride the momentum if it comes. Let’s be real, this is a trader’s stock, not a set-it-and-forget-it play. What’s your strategy here?
<< Previous
Bullboard Posts
Next >>